Toledano-Fonseca, M.; Cano, M.T.; Inga, E.; Gómez-España, A.; Guil-Luna, S.; García-Ortiz, M.V.; Mena-Osuna, R.; De la Haba-Rodriguez, J.R.; Rodríguez-Ariza, A.; Aranda, E.
The Combination of Neutrophil–Lymphocyte Ratio and Platelet–Lymphocyte Ratio with Liquid Biopsy Biomarkers Improves Prognosis Prediction in Metastatic Pancreatic Cancer. Cancers 2021, 13, 1210.
https://doi.org/10.3390/cancers13061210
AMA Style
Toledano-Fonseca M, Cano MT, Inga E, Gómez-España A, Guil-Luna S, García-Ortiz MV, Mena-Osuna R, De la Haba-Rodriguez JR, Rodríguez-Ariza A, Aranda E.
The Combination of Neutrophil–Lymphocyte Ratio and Platelet–Lymphocyte Ratio with Liquid Biopsy Biomarkers Improves Prognosis Prediction in Metastatic Pancreatic Cancer. Cancers. 2021; 13(6):1210.
https://doi.org/10.3390/cancers13061210
Chicago/Turabian Style
Toledano-Fonseca, Marta, M. Teresa Cano, Elizabeth Inga, Auxiliadora Gómez-España, Silvia Guil-Luna, María Victoria García-Ortiz, Rafael Mena-Osuna, Juan R. De la Haba-Rodriguez, Antonio Rodríguez-Ariza, and Enrique Aranda.
2021. "The Combination of Neutrophil–Lymphocyte Ratio and Platelet–Lymphocyte Ratio with Liquid Biopsy Biomarkers Improves Prognosis Prediction in Metastatic Pancreatic Cancer" Cancers 13, no. 6: 1210.
https://doi.org/10.3390/cancers13061210
APA Style
Toledano-Fonseca, M., Cano, M. T., Inga, E., Gómez-España, A., Guil-Luna, S., García-Ortiz, M. V., Mena-Osuna, R., De la Haba-Rodriguez, J. R., Rodríguez-Ariza, A., & Aranda, E.
(2021). The Combination of Neutrophil–Lymphocyte Ratio and Platelet–Lymphocyte Ratio with Liquid Biopsy Biomarkers Improves Prognosis Prediction in Metastatic Pancreatic Cancer. Cancers, 13(6), 1210.
https://doi.org/10.3390/cancers13061210